[1] |
HUANG Xu-hui, SUN Hong, CAI Jia-qin, JU Ming-yu.
URAT1 allele 6092(T/C) polymorphism influence uricosuric action of losartan in hyperuricemia patients with hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(4): 435-440.
|
[2] |
WU Ji-chu, LUO Can-xiang, OU YANG Ze-wei.
Amiodarone and losartan on recurrence and atrial structure for chronic atrial fibrillation after RFCA
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(3): 318-322.
|
[3] |
CHEN Lu-lu, TAN Zhi-rong, YANG Guo-ping, CHEN Xiao-ping, WANG Yi-cheng, CHEN Yao, TIAN Ying-ying, ZHOU Lu-ping, WANG Wen-ping, HE Jia-qi, ZHOU Hong-hao, OUYANG Dong-sheng.
Bioequivalence of losartan potassium tablets and the influence of CYP2C9*3 polymorphism on the metabolism of losartan
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(2): 175-181.
|
[4] |
CHEN Jiang-ying, YAN Zhen-wen, ZHANG Su-ping, YIN Yi-chen.
Protection of losartan on cultured rats hippocampal neurons odels of hypoglycemia anoxia injury in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(9): 984-987.
|
[5] |
PAN Pei, WANG Shi-ming, GUO Zhu-ying, YUAN Yong-fang.
Effect of Ginkgo biloba talbes on the pharmacokinetics of intragastrically administered losartan in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(12): 1326-1331.
|
[6] |
TIAN Jing, LV Ji-yuan, NIU Long-gang.
Effects of losartan on vascular tone of isolated thoracic aortic rings in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(11): 1252-1256.
|
[7] |
GUI Le, ZHU Jian-hua, CHEN Qing-hui.
Losartan inhibits renal sympathetic nerve activity in Paraventricular nucleus in chronic heart failure rat
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(11): 1212-1215.
|
[8] |
QIN Xu-ping, CHEN Yun, QIN You-fa, TIAN Hai-hong, SUN Fei.
Different responses of calcitonin gene-related peptide between losartan and prazosin in early phase of renovascular hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(1): 42-47.
|
[9] |
XIAO Yun-bin, QIN Xu-ping, QIN Li, LIAO Duan-fang, HUANG Hong-lin.
Effects of losartan on expression of matrix metalloproteinase-2,JNK1/2 and proliferation in cardiac fibroblast
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(1): 72-77.
|
[10] |
XIONG Jie, CHENG Liang, ZHANG Li, LI Lin.
Serum pharmacology of Chinese herb complex 962 on increased intracellular calcium
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(8): 876-880.
|
[11] |
XIE Shou-Xia, ZHANG Wang-Fan, DONG Shao-Hong, ZENG Fan-Dian.
Effects oflosartan and captopril on serum digoxin concentration and efficacy inPatients with heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(6): 655-658.
|
[12] |
CHEN Fang, WU Tie.
Antitumor effects of losartan in EAC mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(3): 317-319.
|
[13] |
LIN Wen-Hui, SONG Yu-Kang, MA Xiang-Jun.
Reverse effect of losartan on myocardial fibrosis and left ventricular hypertrophy in treatment of essential hypertensive patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002, 7(6): 539-541.
|
[14] |
TONG Xue-Min, HU Zhao-Liang, CHENG Sheng-Jun.
Clinical evaluation of benazepril alone and combined with losartan in the treatment of congestive heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002, 7(4): 341-343.
|
[15] |
LIANG Xu-Guo, PAN Qi-Xing.
Combination effect of captopril and losartan on cell adhesion molecules and cytokines in the patients with coronary heart disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002, 7(2): 159-161.
|